Bridgewater Associates LP raised its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,856 shares of the biotechnology company’s stock after purchasing an additional 386 shares during the quarter. Bridgewater Associates LP’s […]